Citeline Podcasts

UK medtech industry’s plans to encourage more international business for home-grown companies.

On this week's Medtech Insight podcast: amendments targeting device accessories, medical imaging and post-market surveillance tacked onto FDA Reauthorization Act; a project funded by the US Department of Homeland Security aims to improve device cybersecurity; FDA moves to implement more 21st Century Cures legislation; the Sentinel Cerebral Protection System gains de novo clearance; a report from the MiXii Biomed Life Sciences and Technology Conference in Tel-Aviv.

Compliance 360° Part 9: US FDA Is Looking Closely At Process Validation – Are You Ready? by Informa

On this week's podcast, Tina Tan discusses takeaways from the International Neuromodulation Society congress in Scotland, Reed Miller highlights the best evidence to date supporting patent foramen ovale closure as a treatment to prevent stroke, and Sue Darcey reports on Zika virus diagnostic discussion on Capitol Hill.

The Rose Sheet’s editorial team counts down the top five news items or issues in both the cosmetics and dietary supplement sectors over the past month, including cosmetics reform legislation and its potential bearing on FDA inspections, NGO attacks on sunscreens and developments that could be welcome to companies in terms of how class actions and other litigation are treated by federal courts.

The deadline for entries to the Scrip Awards is fast looming. In this podcast, Mike Ward speaks to Scrip Executive Editor Alex Shimmings, a chair of the Scrip Awards judging panel, about how best to enhance one’s chances to win one the Scrip Awards categories.

On this week's Medtech Insight podcast: US FDA Commissioner Scott Gottlieb defends his agency’s budget; AdvaMed’s new chair talks to Medtech Insight about challenges he faces and where he’s leading the industry group; a close look at mobile technology company Qualcomm Life; a two-part Medtech Insight series on pain management is highlighted.

In an interview to discuss his initial experience as chairman of AdvaMed, Nadim Yared tells Medtech Insight his priority is repealing the medical device excise tax regardless of how such a repeal may affect enrollments in an ACA repeal. Also, while some in industry have expressed concern about the Trump administration's unpredictable nature, Yared says AdvaMed is suited to handle the shifting political winds.

The National Evaluation System for health Technology is finally starting to get off the ground as Rachael Fleurence took the helm last month. In an interview with Medtech Insight the new executive director talks about her qualifications and hopes for the project over the next year and beyond.

On this week's Medtech Insight podcast: ex-US FDA Commissioner Bob Califf talks new commish and Trump; the latest on the Food and Drug Administration Reauthorization Act (FDARA); FDA recommends approval for the TransMedics Organ Care System; blood lead tests made by Magellan Diagnostics may give bad results; updates from the Heart Rhythm and EuroPCR meetings, held in Chicago and France, respectively.